Exemplar hospital initiation trial to enhance treatment engagement (CTN-0098). June 10, 2024 to november 1, 2026. N01DA-22-2253. Task order no. 75N95024F00003 (TO19).
Active Awarded Last action
- Contract number
- 75N95024F00003
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $622,266
Award facts
- Opportunity
-
- 75N95024F00003 Solicitation number
- Contract value 100% obligated
- $622,266.00 Current and potential, with all options
- Completion date 99% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order awarded to The Emmes Company LLC by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA). The $622,266 contract, issued under NIDA's $31.2 million Data, Statistics, and Clinical Trial Support Center indefinite delivery contract, funds an Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (CTN-0098) from June 2024 to November 2026. As a global clinical research organization, The Emmes Company provides data management, statistical analysis, and operational support for NIH clinical trials and research programs across multiple institutes. This task order will likely leverage Emmes' expertise in coordinating multi-site studies, maintaining patient databases, and delivering statistical analysis to advance NIDA's substance abuse research initiatives. The contract has no set-aside designation.
Quick answers
Who was awarded contract 75N95024F00003?
75N95024F00003 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on June 10, 2024.
How much is contract 75N95024F00003 worth?
The government has obligated $622,266 on 75N95024F00003.
Is contract 75N95024F00003 an order under another contract?
Yes. 75N95024F00003 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95024F00003 competed?
The extent of competition for 75N95024F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award